Search - tctmd.com

Displaying 201 - 220 of 260

Sort: Relevancy | Date

Presentation

Impact of Statin Therapy on Late TLR After Sirolimus-Eluting Stent (SES) Implantation

Presenter: 202206|M Natsuaki

March 04, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

News Industry News

Paclitaxel-coated balloon angioplasty demonstrates superior results

November 10, 2011

News Conference News

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

November 09, 2011

News Conference News

Polymer-free DES Shown Effective in Multiple Trials

November 08, 2011

News Conference News

ZES and SES Equally Effective in Long Lesion Treatment

November 08, 2011

News Conference News

Safety, Efficacy Reported with FIREHAWK SES

November 08, 2011

News Conference News

Long-term Outcomes Improved with Biodegradable Biolimus-Eluting Stent vs. Permanent Polymer SES

November 08, 2011

News Conference News

EES Compared Favorably with SES In Two Pivotal Trials

November 08, 2011

News Conference News

ZES Match or Exceed Performance of Earlier DES

November 07, 2011

News Conference News

PAX Studies Highlight Polymer-Free DES Success

November 07, 2011

News Conference News

Efficacy of SES for In-stent Restenosis Dependent on Original Stent Type

November 07, 2011

News Industry News

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

November 07, 2011

News Conference News

DES and Stent Thrombosis Revisited

November 07, 2011

News Industry News

Axxess Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Five Years

November 07, 2011

News Daily News

DES Associated with Less Downstream Lesion Development than BMS

L.A. McKeown

November 04, 2011

News Industry News

Data from REMEDEE Trial Featuring OrbusNeich's ComboTM Dual Therapy Stent to Be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011

November 01, 2011

News Daily News

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

October 17, 2011

Advertisement

Impact of Statin Therapy on Late TLR After Sirolimus-Eluting Stent (SES) Implantation

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Two New SES Show Improvement Over First-Generation Stents

Paclitaxel-coated balloon angioplasty demonstrates superior results

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

Polymer-free DES Shown Effective in Multiple Trials

ZES and SES Equally Effective in Long Lesion Treatment

Safety, Efficacy Reported with FIREHAWK SES

Long-term Outcomes Improved with Biodegradable Biolimus-Eluting Stent vs. Permanent Polymer SES

EES Compared Favorably with SES In Two Pivotal Trials

ZES Match or Exceed Performance of Earlier DES

PAX Studies Highlight Polymer-Free DES Success

Efficacy of SES for In-stent Restenosis Dependent on Original Stent Type

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

DES and Stent Thrombosis Revisited

Axxess Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Five Years

DES Associated with Less Downstream Lesion Development than BMS

Data from REMEDEE Trial Featuring OrbusNeich's ComboTM Dual Therapy Stent to Be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content